In this population-based case-control study, elevated levels of Ang-2 were significantly and independently related to future likelihood of AMI, which is consistent with the notion that an angiogenic compensatory response to silent ischemia or subclinical atherosclerosis may exist even years before the clinical presentation of AMI. The gene discussed is ANGPT2; the disease is atherosclerosis.